Creative Planning’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-84
Closed -$11.8K 2748
2022
Q4
$11.8K Buy
84
+16
+24% +$6.93K ﹤0.01% 2343
2022
Q3
$34K Hold
68
﹤0.01% 2147
2022
Q2
$59K Hold
68
﹤0.01% 2038
2022
Q1
$170K Hold
68
﹤0.01% 1920
2021
Q4
$174K Hold
68
﹤0.01% 1893
2021
Q3
$310K Hold
68
﹤0.01% 1573
2021
Q2
$465K Sell
68
-739
-92% -$5.1M ﹤0.01% 1323
2021
Q1
$5.91M Buy
807
+2
+0.2% +$16.8K 0.01% 373
2020
Q4
$6.5M Buy
805
+5
+0.6% +$44.9K 0.01% 329
2020
Q3
$8.18M Buy
800
+18
+2% +$148K 0.02% 246
2020
Q2
$5.24M Buy
782
+364
+87% +$2.51M 0.02% 281
2020
Q1
$1.89M Buy
418
+32
+8% +$160K 0.01% 450
2019
Q4
$2.34M Buy
386
+102
+36% +$652K 0.01% 467
2019
Q3
$2M Buy
284
+1
+0.4% +$7.28K 0.01% 491
2019
Q2
$1.84M Hold
283
0.01% 527
2019
Q1
$2.35M Hold
283
0.01% 417
2018
Q4
$1.57M Buy
283
+120
+74% +$919K 0.01% 487
2018
Q3
$1.44M Buy
163
+23
+16% +$187K 0.01% 597
2018
Q2
$1.2M Hold
140
﹤0.01% 654
2018
Q1
$723K Hold
140
﹤0.01% 895
2017
Q4
$722K Buy
+140
New +$943K ﹤0.01% 882
2017
Q3
Sell
-1
Closed -$9K 3304
2017
Q2
$9K Hold
1
﹤0.01% 3697
2017
Q1
$10K Hold
1
﹤0.01% 3602
2016
Q4
$10K Hold
1
﹤0.01% 3563
2016
Q3
$14K Hold
1
﹤0.01% 3281
2016
Q2
$11K Hold
1
﹤0.01% 3197
2016
Q1
$12K Buy
+1
New +$10.5K ﹤0.01% 3119

Other funds holding RDHL

Creative Planning's RDHL Position: Q1 2023 in Review

Creative Planning sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 84 shares — an estimated $11.8K sold.

Creative Planning first reported a position in RDHL in Q1 2016 and held it in 27 quarters. The position peaked at $8.18M in Q3 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Creative Planning reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Creative Planning sold 84 Redhill Biopharma shares in Q1 2023, an estimated $11.8K.
  • Creative Planning first reported a position in Redhill Biopharma in Q1 2016 and held it in 27 quarters.
  • Creative Planning's Redhill Biopharma position peaked at $8.18M in Q3 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Creative Planning's 13F filing for Q1 2023, filed 15 May 2023.